Gabriel Plotkin Charles River Laboratories International, Inc. Transaction History

Melvin Capital Management LP

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$204.13 - $302.4 $161 Million - $239 Million
-790,956 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$255.51 - $362.11 $32.9 Million - $46.7 Million
128,950 Added 19.48%
790,956 $225 Million
Q4 2021

Feb 14, 2022
BUY
$351.38 - $448.68 $101 Million - $129 Million
287,006 Added 76.53%
662,006 $249 Million
Q3 2021

Nov 15, 2021
BUY
$372.64 - $458.3 $140 Million - $172 Million
375,000 New
375,000 $155 Million

Others Institutions Holding CRL

# of Institutions
714
Shares Held
51.7M
Call Options Held
233K
Put Options Held
236K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.6B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track Gabriel Plotkin's Portfolio

Track Gabriel Plotkin Portfolio

Follow Gabriel Plotkin (Melvin Capital Management LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Melvin Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Melvin Capital Management LP and Gabriel Plotkin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email